search icon
  • Print
  • ShareThis
  • Text Size

RSS Feed Print Category View
FDA approves Sovaldi for chronic hepatitis C
ThomasKim
Posted: Monday, December 9, 2013 9:08 AM
Joined: 2/20/2013
Posts: 38


"The U.S. Food and Drug Administration today approved Sovaldi (sofosbuvir) to treat chronic hepatitis C virus (HCV) infection. Sovaldi is the first drug that has demonstrated safety and efficacy to treat certain types of HCV infection without the need for co-administration of interferon.

 
'Today’s approval represents a significant shift in the treatment paradigm for some patients with chronic hepatitis C,' said Edward Cox, M.D., director of the Office of Antimicrobial Products in the FDA’s Center for Drug Evaluation and Research.

 

Sovaldi is the second drug approved by the FDA in the past two weeks to treat chronic HCV infection. On November 22, the FDA approved Olysio (simeprevir)."

 

To read more, please visit: 

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm377888.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery

Also, please see the attached New York Times article, "F.D.A. Approves Pill to Treat Hepatitis C."


File Attachment(s):
FDA approves Sovaldi - Gilead Science - Dec 6 2013 - NYTimes.doc (45056 bytes)

 

| HIVMA | Contact Us

© Copyright IDSA 2014 Infectious Diseases Society of America

Full Site Mobile Site